Company Filing History:
Years Active: 2025
Title: Innovations in Colorectal Cancer Detection by Rui Yang
Introduction
Rui Yang is an accomplished inventor based in Burlingame, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. His innovative approach utilizes advanced techniques in nucleic acid methylation analysis to improve cancer screening methods.
Latest Patents
Rui Yang holds a patent for "Methods and systems for detecting colorectal cancer via nucleic acid methylation analysis." This patent outlines a method for screening or detecting colorectal cancer by analyzing cell-free nucleic acids, such as cell-free DNA. The method employs the detection of methylation signals within a single sequencing read in specific genomic regions. This information is then used to train a machine learning model, which generates a classifier that can stratify populations based on their health status, including healthy individuals, cancer patients, and those with different disease subtypes or stages. The method is designed to predict, prognosticate, and monitor responses to treatment, tumor load, relapse, or the development of colorectal cancer.
Career Highlights
Rui Yang is currently associated with Freenome Holdings, Inc., where he continues to advance his research in cancer detection technologies. His work is pivotal in enhancing the accuracy and efficiency of colorectal cancer screening, which can lead to better patient outcomes.
Collaborations
Rui collaborates with notable colleagues, including John St John and Steven Kothen-hill. Their combined expertise contributes to the innovative research and development efforts at Freenome Holdings, Inc.
Conclusion
Rui Yang's contributions to colorectal cancer detection through innovative methodologies highlight the importance of research in improving medical diagnostics. His work not only advances scientific knowledge but also has the potential to save lives through early detection and treatment.